Connect Biopharma Holdings Ltd. (CNTB)
0.6044
-0.02
(-3.79%)
USD |
NASDAQ |
Nov 20, 10:20
Connect Biopharma Holdings Cash from Operations (Quarterly) : -12.31M for Sept. 30, 2026
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | -12.31M |
| June 30, 2026 | -16.19M |
| March 31, 2026 | -16.00M |
| December 31, 2025 | -11.60M |
| Date | Value |
|---|---|
| September 30, 2025 | -17.70M |
| June 30, 2025 | -12.66M |
| March 31, 2025 | -9.959M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Quarterly) Benchmarks
| Anavex Life Sciences Corp. | -9.096M |
| Vaxcyte, Inc. | -224.08M |
| Foghorn Therapeutics, Inc. | -18.24M |
| Caribou Biosciences, Inc. | -22.52M |
| Oncolytics Biotech, Inc. | -6.754M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | 1.517M |
| Cash from Financing (Quarterly) | 0.0668M |
| Free Cash Flow | -56.12M |
| Free Cash Flow Per Share (Quarterly) | -0.1955 |
| Free Cash Flow to Equity (Quarterly) | -12.21M |
| Free Cash Flow to Firm (Quarterly) | -12.31M |
| Free Cash Flow Yield | -152.6% |